U.S. Markets close in 3 hrs 37 mins

Durata Therapeutics, Inc. (DRTX) in Focus: Stock Up 5.4%

Zacks Equity Research

Durata Therapeutics, Inc. (DRTX) was a big mover last session, as the company saw its shares jump 5.4% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $13.58 to $14.64 in the past one-month time frame.

In the last 30 days, the company witnessed no estimate revisions. However, the Zacks Consensus Estimate, pegged at a loss, has widened over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.

Durata Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. (ALIOF) and Cambrex Corporation.(CBM) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

DURATA THERAPEUTICS INC (DRTX): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


CAMBREX CORP (CBM): Free Stock Analysis Report

Zacks Investment Research